Sanofi India Ltd.

NSE: SANOFI | BSE: 500674 | ISIN: INE058A01010 | Industry: Pharmaceuticals
| Mid-range Performer
6164.5000 -19.50 (-0.32%)
NSE Jun 11, 2025 15:31 PM
Volume: 6,699
 

logo
Sanofi India Ltd.
22 Feb 2018
6164.50
-0.32%
Motilal Oswal
Sanofi's (SANL) 4QCY17 revenue increased ~ 13% YoY to INR6.7b (~2.8%miss). Revenue growth adjusted for GST was 14%. EBITDA rose 25% YoY toINR1.3b (8.8% miss), with the margin expanding ~190bp YoY to 20%. SANL incurred one-time expense of INR162m for abundant precaution (related to legal case), adjusting for which margin would have been 22.5%. PAT increased 50% YoY to INR760m, led by healthy revenue growth and margin improvement. For CY17, sales, EBITDA and PAT stood at INR24.9b (+5.5%YoY), INR5.4b (+1.7% YoY) and INR3.3b (+9.8% YoY), respectively.
Sanofi India Ltd. is trading below its 200 day SMA of 6167.6
More from Sanofi India Ltd.
Recommended